Company research
biote Corp.
CIK 1819253Updated Sep 24, 2026
SecurityBTMD · NASDAQ · equity
Name history
Haymaker Acquisition Corp. III · through May 25, 2022
BTMD price & chart
Loading TradingView…
NASDAQ:BTMD on TradingView ↗About the company
Biote advances the healthspan of our Practitioners’ patients by providing innovative hormone optimization and healthy aging solutions. Through our network of Biote certified providers, we collaborate with leading clinicians to restore vitality and promote vibrant aging.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
4 filing
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 107,613,000Source | 122,370,000Source | 155,295,000Source | 111,645,000Source |
| Property, Plant and Equipment, NetUSD | 10,753,000Source | 6,973,000Source | 1,218,000Source | 1,504,000Source |
| GoodwillUSD | 5,833,000Source | 5,833,000Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 4,266,000Source | 5,500,000Source | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 24,123,000Source | 39,342,000Source | 89,002,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,868,000Source | 7,631,000Source | 6,809,000Source | 6,948,000Source |
| Inventory, NetUSD | 19,064,000Source | 14,845,000Source | 17,307,000Source | 11,183,000Source |
| Assets, CurrentUSD | 54,670,000Source | 68,127,000Source | 122,343,000Source | 101,178,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,615,000Source | 6,309,000Source | 9,225,000Source | 3,816,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,701,000Source | 3,246,000Source | 1,877,000Source | 2,052,000Source |
| Other Assets, NoncurrentUSD | 72,000Source | 72,000Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 158,010,000Source | 224,570,000Source | 191,841,000Source | 169,919,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | 0Source | 0Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -49,549,000Source | -100,297,000Source | -29,391,000Source | -44,460,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -29,000Source | -35,000Source | -12,000Source | -5,000Source |
| Stockholders' Equity Attributable to ParentUSD | -58,539,000Source | -105,928,000Source | -29,397,000Source | -44,459,000Source |
| Liabilities and EquityUSD | 107,613,000Source | 122,370,000Source | 155,295,000Source | 111,645,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 44,991,000Source | 51,514,000Source | 22,215,000Source | 18,766,000Source |
| Operating Lease, Liability, CurrentUSD | 592,000Source | 523,000Source | 311,000Source | 165,000Source |
| Accounts Payable, CurrentUSD | 6,826,000Source | 5,813,000Source | 4,155,000Source | 4,112,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,298,000Source | 2,890,000Source | 1,680,000Source | 1,927,000Source |
| Other Liabilities, NoncurrentUSD | 344,000Source | 1,500,000Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 8,142,000Source | 3,728,000Source | -7,149,000Source | -13,815,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,806,000Source | 11,293,000Source | 8,497,000Source | 6,274,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 6,250,000Source | 6,250,000Source | 6,250,000Source | 6,250,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 95,782,000Source | 101,199,000Source | 106,630,000Source | 112,086,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 31,597,000Source | 46,000Source | -2,805,000Source | 1,324,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 3,670,000Source | 3,574,000Source | 2,994,000Source | 2,199,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 8,921,000Source | 8,735,000Source | 9,057,000Source | 82,180,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 958,000Source | 2,267,000Source | 505,000Source | 1,562,000Source |
| Increase (Decrease) in InventoriesUSD | 6,242,000Source | -3,714,000Source | 6,098,000Source | 1,708,000Source |
| Increase (Decrease) in Accounts PayableUSD | 1,013,000Source | 1,545,000Source | -165,000Source | 416,000Source |
| Deferred Income Tax Expense (Benefit)USD | 3,973,000Source | -2,898,000Source | 721,000Source | -743,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 35,194,000Source | 45,243,000Source | 26,883,000Source | -9,157,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | 11,842,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -6,864,000Source | -18,798,000Source | -2,713,000Source | -1,838,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 5,015,000Source | 6,430,000Source | 359,000Source | 333,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 3,365,000Source | 5,599,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -43,555,000Source | -76,083,000Source | -14,380,000Source | 63,460,000Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -15,219,000Source | -49,660,000Source | 9,771,000Source | 52,465,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 7,877,000Source | 9,535,000Source | 9,476,000Source | 4,426,000Source |
| Income Taxes Paid, NetUSD | 2,752,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 0Source |
| Amortization of Debt Issuance CostsUSD | 833,000Source | 819,000Source | 794,000Source | 589,000Source |
| Amortization of Intangible AssetsUSD | 1,200,000Source | 1,200,000Source | — | — |
| Capitalized Computer Software, AmortizationUSD | 1,200,000Source | 1,600,000Source | 2,200,000Source | 1,035,000Source |
| DepreciationUSD | — | 800,000Source | 800,000Source | 1,164,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | -13,853,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | -445,000Source |
| GoodwillUSD | 5,833,000Source | 5,833,000Source | — | — |
| Income Tax Expense (Benefit)USD | 5,987,000Source | 970,000Source | 2,682,000Source | 388,000Source |
| Inventory Write-downUSD | 2,023,000Source | 503,000Source | -26,000Source | 140,000Source |
| Net Income (Loss) Attributable to ParentUSD | 27,045,000Source | 3,157,000Source | 3,316,000Source | -969,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 4,552,000Source | -3,111,000Source | -6,121,000Source | 2,293,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 27,045,000Source | 3,157,000Source | 3,316,000Source | -969,000Source |
| Nonoperating Income (Expense)USD | 2,033,000Source | -30,595,000Source | -28,780,000Source | 62,434,000Source |
| Other Nonoperating Income (Expense)USD | -29,000Source | 11,000Source | -16,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 226,000Source | 2,390,000Source | 420,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 192,219,000Source | 197,191,000Source | 185,360,000Source | 164,957,000Source |
| Selling, General and Administrative ExpenseUSD | 101,810,000Source | 107,450,000Source | 98,826,000Source | 165,502,000Source |
| Operating Income (Loss)USD | 35,551,000Source | 31,611,000Source | 28,657,000Source | -60,722,000Source |
| Other Nonoperating Income (Expense)USD | -29,000Source | 11,000Source | -16,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 37,584,000Source | 1,016,000Source | -123,000Source | 1,712,000Source |
| Income Tax Expense (Benefit)USD | 5,987,000Source | 970,000Source | 2,682,000Source | 388,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 4,552,000Source | -3,111,000Source | -6,121,000Source | 2,293,000Source |
| Net Income (Loss) Attributable to ParentUSD | 27,045,000Source | 3,157,000Source | 3,316,000Source | -969,000Source |
| Earnings Per Share, BasicUSD per share | 0.86Source | 0.09Source | 0.13Source | -0.12Source |
| Earnings Per Share, DilutedUSD per share | 0.74Source | 0.09Source | 0.13Source | -0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 31,283,245Source | 34,270,809Source | 25,709,343Source | 8,059,371Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 36,666,766Source | 34,270,809Source | 25,709,343Source | 8,059,371Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,200,000Source | 1,200,000Source | — | — |
| Capitalized Computer Software, AmortizationUSD | 1,200,000Source | 1,600,000Source | 2,200,000Source | 1,035,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 54,858,000Source | 58,130,000Source | 57,877,000Source | 54,575,000Source |
| Current Income Tax Expense (Benefit)USD | 2,014,000Source | 3,868,000Source | 1,961,000Source | 1,131,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | -13,853,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 37,967,000Source | 1,324,000Source | 300,000Source | 2,221,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -10,961,000Source | -11,001,000Source | -6,363,000Source | -5,091,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 27,045,000Source | 3,157,000Source | 3,316,000Source | -969,000Source |
| Nonoperating Income (Expense)USD | 2,033,000Source | -30,595,000Source | -28,780,000Source | 62,434,000Source |
Filing attachments
btmd-ex99_1.htm · 8-K · 2026-08-05
EX-99.1 2 btmd-ex99_1.htm EX-99.1 EX-99.1 Biote Reports Second Quarter 2026 Financial Results Continued progress in advancing strategic initiatives Updates full-year outlook Second Quarter 2026 Financial Highlights • Revenue of $44.2 million • Gross profit margin of 65.4% • Net loss of $(7.4) million and diluted loss per share attributable to biote Corp. stockholders of $(0.23), compared to net income of $3.9 million and diluted earnings per share attributable to biote Corp. stockhold…
Read attachment ↗d215108dex991.htm · 8-K · 2026-06-02
EX-99.1 2 d215108dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO Bret Christensen Stepping Down as CEO for Family and Personal Reasons, Remains a Director Company Reaffirms Full Year 2026 Guidance IRVING, TX - (BUSINESS WIRE) - May 28, 2026 - Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today ann…
Read attachment ↗btmd-ex99_1.htm · 8-K · 2026-05-06
EX-99.1 2 btmd-ex99_1.htm EX-99.1 EX-99.1 Biote Reports First Quarter 2026 Financial Results Sales team expansion on track and nearing targeted level Return to procedure growth expected in second half of 2026 First Quarter 2026 Financial Highlights • Revenue of $44.9 million • Gross profit margin of 68.9% • Net income of $2.7 million and diluted earnings per share attributable to biote Corp. stockholders of $0.06, compared to net income of $15.8 million and diluted earnings per share …
Read attachment ↗d126766dex991.htm · 8-K · 2026-04-03
EX-99.1 2 d126766dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Transforming Healthy Aging 2 Transforming Healthy Aging Forward-Looking Statements Forward-Looking Statements Certain statements in this Presentation may be considered “forward-looking statements” within the meaning of the provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events of BioTE Holdings, LLC’s (“BioTE” or the “Company”) future financial or…
Read attachment ↗